If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
360.40    0.00 (0.00%)
Bid:
360.00
Ask:
360.60
Spread: 0.60 (0.167%)
Market Cap: £1.91b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim Dividend and Enhanced Scrip Alternative

8 Dec 2020 13:15

RNS Number : 9480H
Hammerson PLC
08 December 2020
 

THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

Hammerson plc

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

8 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124

 

Therefore, 189,816,827 New Shares will be admitted to trading on the London Stock Exchange and 36,013,297 New Shares will be admitted to trading on the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange.

 

Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholder-information/general-meeting.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVTPBTTMTJMBLM
Date   Source Headline
11th Oct 20244:50 pmRNSDirector/PDMR Shareholding
9th Oct 202412:00 pmRNSShare capital reduction confirmation
9th Oct 20247:00 amRNSHammerson Completes Refinancing Transactions
8th Oct 20243:00 pmRNSDirector/PDMR Shareholding
8th Oct 20241:30 pmRNSFinal Results of the Tender Offers
8th Oct 202410:30 amRNSIndicative Results of Tender Offers
7th Oct 20247:00 amRNSPublication of Final Terms
4th Oct 20241:30 pmRNSDirector/PDMR Shareholding
3rd Oct 202411:00 amRNSMaximum Acceptance Amount for the Tender Offers
3rd Oct 20247:30 amRNSHammerson announces pricing of 12-year £400m bond
2nd Oct 202411:30 amRNSHolding(s) in Company
1st Oct 202411:29 amRNSCash Fractional Entitlements
30th Sep 20248:30 amRNSTotal Voting Rights
27th Sep 20243:45 pmRNSShare Consolidation
27th Sep 202411:00 amRNSHolding(s) in Company
27th Sep 20249:02 amRNSPotential new Sterling-denominated issuance
27th Sep 20249:01 amRNSBond Tender Offers
27th Sep 20249:00 amRNSEMTN Establishment and Publication of Prospectus
18th Sep 202411:15 amRNSDisposal
17th Sep 202411:00 amRNSDirector/PDMR Shareholding
12th Sep 20242:00 pmRNSResult of General Meeting
27th Aug 20244:00 pmRNSDirector/PDMR Shareholding
27th Aug 20242:30 pmRNSHolding(s) in Company
27th Aug 202411:00 amRNSHolding(s) in Company
21st Aug 202411:30 amRNSHolding(s) in Company
19th Aug 202412:00 pmRNSDirector/PDMR Shareholding
16th Aug 20242:30 pmRNSHolding(s) in Company
14th Aug 20249:00 amRNSDividend Currency Conversion Announcement
14th Aug 20247:00 amRNSRefinancing of secured loan on Dundrum Town Centre
13th Aug 202412:30 pmRNSDirector/PDMR Shareholding
8th Aug 202410:00 amRNSCircular, Notice of Meeting and Form of Proxy
31st Jul 20244:00 pmRNSDirector/PDMR Shareholding
29th Jul 20243:30 pmRNSHolding(s) in Company
25th Jul 20247:01 amRNSDividend Declaration
25th Jul 20247:00 amRNSHalf-year Report
22nd Jul 20247:00 amRNSDisposal of Hammerson’s interest in Value Retail
19th Jul 20244:45 pmRNSHolding(s) in Company
8th Jul 20244:15 pmRNSHolding(s) in Company
25th Jun 202410:30 amRNSNotice of Results
24th Jun 20244:00 pmRNSHolding(s) in Company
18th Jun 20242:00 pmRNSHolding(s) in Company
14th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:15 pmRNSHolding(s) in Company
7th Jun 202410:00 amRNSDirector/PDMR Shareholding
5th Jun 202411:30 amRNSHolding(s) in Company
3rd Jun 202412:15 pmRNSDirector/PDMR Shareholding
31st May 20244:30 pmRNSBlock Listing Six Monthly Return and Cancellation
31st May 202410:00 amRNSDirector/PDMR Shareholding
30th May 20244:30 pmRNSDirector/PDMR Shareholding - Replacement
24th May 20244:00 pmRNSResults of Dividend Reinvestment Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.